Norway's crown princess undergoes successful lung transplant, palace says

Norway's Crown Princess Mette-Marit speaks during this year's Fosse Lecture at the Palace, in Oslo, Norway, on April 23.

OSLO – Norway’s Crown Princess Mette-Marit has undergone a successful lung transplant and will remain in hospital for several weeks as she begins her recovery, doctors at Oslo University Hospital said on June 17.

The 52-year-old wife of Crown Prince Haakon, the heir to the Norwegian throne, was diagnosed with pulmonary fibrosis in 2018, a chronic disease that causes scarring in the lungs and leads to a reduced oxygen uptake.

The hospital said the transplant had “so far” been successful, in a statement provided by the palace, but without specifying exactly when the procedure took place.

“Like all newly transplanted patients, the crown princess will remain at the hospital for several weeks to come,” Oslo University Hospital professor Are Holm said.

The time would be spent adjusting medication, managing potential complications and beginning physical rehabilitation, he said.

The surgery comes at a strained time for the royal family: earlier this week, Mette-Marit’s 29-year-old son from a previous relationship, Marius Borg Hoiby, was convicted of rape and domestic violence and sentenced to four years in prison. Hoiby plans to appeal, his lawyer has said.

Oslo University Hospital on June 5 said Mette-Marit had been placed on a waiting list for a lung transplant after a significant deterioration in her health that likely gave her only a year to live without the surgery.

The crown prince and crown princess thanked the public for their messages of support, the palace said. The next public update on her health is only expected when she is discharged from hospital, it added.

Around 30 to 35 lung transplants are performed in Norway each year, and hospital officials have stressed that members of the royal family receive no preferential treatment in receiving new organs.

While waiting lists are relatively short, strict criteria must be met for a transplant to succeed, Holm said earlier in June.

“It has to be the right size, it must be the correct blood type, and we have to make sure that the recipient doesn’t have antibodies against the tissue type of the organ,” he told reporters.

“It’s about getting the right organ to the right person. This means that many factors have to align to increase the chances of success.”

Up to 90 per cent of lung transplant patients in Norway survive the first year after surgery, while around 55 per cent are still alive after 10 years, according to Oslo University Hospital data.

Crown Prince Haakon in Decem